Header Logo

Connection

KEVIN MACKENZIE to Cell Line, Tumor

Back to Details
This is a "connection" page, showing publications KEVIN MACKENZIE has written about Cell Line, Tumor.
KEVIN MACKENZIE
Connection Strength
0.035
Cell Line, Tumor
  1. Lead Compound Development of SRC-3 Inhibitors with Improved Pharmacokinetic Properties and Anticancer Efficacy. J Med Chem. 2024 04 11; 67(7):5333-5350.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.